Using probiotics to treat ulcerative colitis and irritable bowel syndrome

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the efficacy of probiotics in patients diagnosed with mild to moderate ulcerative colitis (UC) and irritable bowel syndrome (IBS). Participants will be randomly assigned to receive either conventional treatment combined with probiotics or a placebo. The study aims to assess the impact of probiotics on intestinal flora, inflammatory markers, and overall gut health. By exploring the mechanisms through which probiotics may alleviate symptoms, the trial seeks to provide new therapeutic options for patients suffering from these conditions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Clinical diagnosis of ulcerative colitis
* Clinical diagnosis of irritable bowel
* Can swallow probiotic pellets as required

Exclusion Criteria:

* indeterminate colitis,suspected IBD

Where it's running

• The First Affiliated Hospital of Xinxiang Medical College
  Xinxiang, Henan, China Recruiting

Study contacts

• Study coordinator: Minhao M Zheng, undergraduate
• Email: mhzhbz@126.com
• Phone: 15651351756

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using fecal microbiota transplantation to treat gut disorders

  This study is testing whether a treatment that involves using healthy stool to help restore gut bacteria can improve symptoms for people with gut disorders like Crohn's disease and irritable bowel syndrome.

  Recruiting Chinese University of Hong Kong · Hong Kong, Shatin · NCT04014413

• Innovative Multidisciplinary and Virtual Care for IBD in Pregnancy

  This study tests a dedicated IBD pregnancy care model, including a new virtual approach, to see if it improves access and quality of care for pregnant people with Crohn's disease or ulcerative colitis.

  Recruiting at 5 sites Austin Health · Hobart and 6 other locations · NCT07916727

• Liver Fat and Scarring in People Suspected of Non-Celiac Wheat Sensitivity

  This study looks to see if people with non-celiac wheat sensitivity have liver fat or fibrosis and how this relates to IBS/FD and celiac disease.

  Recruiting at 2 sites University of Palermo · Palermo, Palermo and 1 other locations · NCT07750535

• A Probiotic Approach to Modulating Gut Microbiota in Mild-to-Moderate Ulcerative Colitis

  A specific probiotic given rectally will be tested in adults with mild-to-moderate ulcerative colitis to see if it can help manage symptoms.

  Recruiting Catholic University of the Sacred Heart · Roma, RM · NCT07724990

• Advanced therapies for moderately to severely active Crohn's disease or ulcerative colitis in adults

  This study tests combinations of risankizumab with either trosunilimab or ABBV-701 in adults with moderately to severely active Crohn's disease or ulcerative colitis.

  Recruiting at 66 sites Phase 2 AbbVie · Dothan, Alabama and 65 other locations · NCT07697456

• Longitudinal Immunophenotyping of People with Inflammatory Bowel Disease

  This study will follow adults with Crohn's disease or ulcerative colitis (and some healthy relatives) over three years to see how their immune cells change over time and how genetics and diet relate to their disease.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07619547

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.